Evidence map›Paper›PMID 38158503›Full record

ArticlePharmaceutical research2024

Comparative Study of Dermal Pharmacokinetics Between Topical Drugs Using Open Flow Microperfusion in a Pig Model.

Manfred Bodenlenz, Thean Yeoh, Gabriel Berstein, Shibin Mathew, Jaymin Shah, Christopher Banfield, Brett Hollingshead, Stefanus J Steyn, Sarah M Osgood, Kevin Beaumont and 5 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Pharmaceutical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Manfred BodenlenzHEALTH - Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft M.B.H, Neue Stiftingtalstrasse 2, 8010, Graz, Austria.
Thean YeohPfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA.
Gabriel BersteinPfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA.
Shibin MathewPfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA. Shibin.Mathew@pfizer.com.
Jaymin ShahPfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA.
Christopher BanfieldPfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA.
Brett HollingsheadPfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA.
Stefanus J SteynPfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA.
Sarah M OsgoodPfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA.
Kevin BeaumontPfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA.
Sonja KainzHEALTH - Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft M.B.H, Neue Stiftingtalstrasse 2, 8010, Graz, Austria.
Christian HolečekHEALTH - Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft M.B.H, Neue Stiftingtalstrasse 2, 8010, Graz, Austria.
Gert TrausingerHEALTH - Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft M.B.H, Neue Stiftingtalstrasse 2, 8010, Graz, Austria.
Reingard RamlHEALTH - Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft M.B.H, Neue Stiftingtalstrasse 2, 8010, Graz, Austria.
Thomas BirngruberHEALTH - Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft M.B.H, Neue Stiftingtalstrasse 2, 8010, Graz, Austria. healthca@joanneum.at.
Pfizer (United States) · USJoanneum Research · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAccurate methods to determine dermal pharmacokinetics are important to increase the rate of clinical success in topical drug development. We investigated in an in vivo pig model whether the unbound drug concentration in the interstitial fluid as determined by dermal open flow microperfusion (dOFM) is a more reliable measure of dermal exposure compared to dermal biopsies for seven prescription or investigational drugs. In addition, we verified standard dOFM measurement using a recirculation approach and compared dosing frequencies (QD versus BID) and dose strengths (high versus low drug concentrations).

methodsDomestic pigs were topically administered seven different drugs twice daily in two studies. On day 7, drug exposures in the dermis were assessed in two ways: (1) dOFM provided the total and unbound drug concentrations in dermal interstitial fluid, and (2) clean punch biopsies after heat separation provided the total concentrations in the upper and lower dermis.

resultsdOFM showed sufficient intra-study precision to distinguish interstitial fluid concentrations between different drugs, dose frequencies and dose strengths, and had good reproducibility between studies. Biopsy concentrations showed much higher and more variable values. Standard dOFM measurements were consistent with values obtained with the recirculation approach.

conclusionsdOFM pig model is a robust and reproducible method to directly determine topical drug concentration in dermal interstitial fluid. Dermal biopsies were a less reliable measure of dermal exposure due to possible contributions from drug bound to tissue and drug associated with skin appendages.

Indexed as

SkinAdministration, CutaneousAnimalsReproducibility of ResultsSwinecandidatesclinical efficacycompoundsfree drug hypothesisin vivo animal model

Identifiers

PMID38158503
PMCPMC10879402
OpenAlexW4390401015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.